Listed by the USPTO as ROONEY, NORA MAUREEN
Tech Center 1600 • Art Units: 1641 1644 1646
This examiner grants 60% of resolved cases
ROONEY, NORA MAUREEN handles cases in tech center 1600 and art unit 1641. The profile reports 751 resolved cases, a 60.5% allowance rate, and a median of 1272 days to allowance. The 23.4% interview lift indicates a meaningful positive association between interviews and allowance outcomes.
The listed companies are Boehringer Ingelheim International GmbH, Massachusetts Institute of Technology, and Kashiv Biosciences LLC. The listed firms are Kilpatrick Townsend & Stockton LLP - West Coast, BakerHostetler, and Fox Rothschild LLP - JHU. Applicants should plan for the extended median timing and can incorporate interviews into a prosecution strategy focused on moving claims toward allowance.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18267795 | BIFUNCTIONAL ANTI-PD1/IL-7 MOLECULES | Non-Final OA | BOEHRINGER INGELHEIM INTERNATIONAL GMBH |
| 18117752 | TRANSMUCOSAL AMPHIPHILE-PROTEIN CONJUGATE VACCINE | Final Rejection | Massachusetts Institute of Technology |
| 19282184 | PROCESS OF PURIFICATION OF PROTEIN | Non-Final OA | Kashiv BioSciences, LLC |
| 18015684 | COMPREHENSIVE ANALYSIS OF ANTI-ALLERGEN ANTIBODIES USING PHAGE DISPLAY | Non-Final OA | THE JOHNS HOPKINS UNIVERSITY |
| 18016243 | TARGET-RECOGNITION OF ANTIGEN-MHC COMPLEX REPORTER (TRACER) PLATFORM | Non-Final OA | The Board of Trustees of the Leland Stanford Junior University |
| 18669172 | Anti-CTLA-4 Antibodies and Uses Thereof | Non-Final OA | Regeneron Pharmaceuticals, Inc. |
| 17797540 | METHODS FOR PRODUCING AND/OR ENRICHING RECOMBINANT ANTIGEN-BINDING MOLECULES | Final Rejection | Chugai Seiyaku Kabushiki Kaisha |
| 17046199 | AXL-SPECIFIC ANTIBODIES FOR CANCER TREATMENT | Non-Final OA | GENMAB A/S |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy60.5% of resolved applications examined by Nora Maureen Rooney were allowed (751 resolved cases), compared with 45.2% across Art Unit 1641 over the last five years.
This examiner's interview lift is +23.4 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Nora Maureen Rooney took 1,272 days on average from filing to allowance.
Nora Maureen Rooney examines applications in Art Unit 1641 in Tech Center 1600 (Biotechnology & Pharmaceuticals).
